Alpha 2.0
Login Register
» Articles » PMID: 12209762

Serum CYFRA 21-1 is One of the Most Reliable Tumor Markers for Breast Carcinoma

Overview
Journal Cancer
Publisher Wiley
Specialty Oncology
Date 2002 Sep 5
PMID 12209762
Citations 5
Authors
Cesar A Rodriguez
Juan J Cruz
Teresa Martin
Amalia Gomez
Amaya Olaverri
Marisa Hernandez
Affiliations
Soon will be listed here.
Citing Articles

A Diagnostic Analysis Workflow to Optimal Multiple Tumor Markers to Predict the Nonmetastatic Breast Cancer from Breast Lumps.

Jiang N, Tian T, Chen X, Zhang G, Pan L, Yan C J Oncol. 2021; 2021:5579373.

PMID: 34335759 PMC: 8289572. DOI: 10.1155/2021/5579373.

Serum CYFRA 21.1 Level Predicts Disease Course in Thyroid Cancer with Distant Metastasis.

Jeong C, Lee J, Yoon H, Ha J, Kim M, Bae J Cancers (Basel). 2021; 13(4).

PMID: 33671989 PMC: 7919275. DOI: 10.3390/cancers13040811.

Fine-needle aspirate CYFRA 21-1, an innovative new marker for diagnosis of axillary lymph node metastasis in breast cancer patients.

Choi J, Han K, Kim E, Moon H, Yoon J, Kim M Medicine (Baltimore). 2015; 94(19):e811.

PMID: 25984666 PMC: 4602573. DOI: 10.1097/MD.0000000000000811.

Fine-needle aspirates CYFRA 21-1 is a useful tumor marker for detecting axillary lymph node metastasis in breast cancer patients.

Yoon J, Han K, Kim E, Moon H, Kim M, Suh Y PLoS One. 2013; 8(2):e57248.

PMID: 23451192 PMC: 3581445. DOI: 10.1371/journal.pone.0057248.

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer.

Nakata B, Takashima T, Ogawa Y, Ishikawa T, Hirakawa K Br J Cancer. 2004; 91(5):873-8.

PMID: 15280913 PMC: 2409884. DOI: 10.1038/sj.bjc.6602074.